Cargando…

Newcastle Disease Virus Fusion Protein Is the Major Contributor to Protective Immunity of Genotype-Matched Vaccine

Virulent strains of Newcastle disease virus (NDV) can cause devastating disease in chickens worldwide. Although the current vaccines are substantially effective, they do not completely prevent infection, virus shedding and disease. To produce genotype-matched vaccines, a full-genome reverse genetics...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Shin-Hee, Wanasen, Nanchaya, Paldurai, Anandan, Xiao, Sa, Collins, Peter L., Samal, Siba K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755997/
https://www.ncbi.nlm.nih.gov/pubmed/24015313
http://dx.doi.org/10.1371/journal.pone.0074022
_version_ 1782282017692450816
author Kim, Shin-Hee
Wanasen, Nanchaya
Paldurai, Anandan
Xiao, Sa
Collins, Peter L.
Samal, Siba K.
author_facet Kim, Shin-Hee
Wanasen, Nanchaya
Paldurai, Anandan
Xiao, Sa
Collins, Peter L.
Samal, Siba K.
author_sort Kim, Shin-Hee
collection PubMed
description Virulent strains of Newcastle disease virus (NDV) can cause devastating disease in chickens worldwide. Although the current vaccines are substantially effective, they do not completely prevent infection, virus shedding and disease. To produce genotype-matched vaccines, a full-genome reverse genetics system has been used to generate a recombinant virus in which the F protein cleavage site has been changed to that of avirulent vaccine virus. In the other strategy, the vaccines have been generated by replacing the F and HN genes of a commercial vaccine strain with those from a genotype-matched virus. However, the protective efficacy of a chimeric virus vaccine has not been directly compared with that of a full-genome virus vaccine developed by reverse genetics. Therefore, in this study, we evaluated the protective efficacy of genotype VII matched chimeric vaccines by generating three recombinant viruses based on avirulent LaSota (genotype II) strain in which the open reading frames (ORFs) encoding the F and HN proteins were replaced, individually or together, with those of the circulating and highly virulent Indonesian NDV strain Ban/010. The cleavage site of the Ban/010 F protein was mutated to the avirulent motif found in strain LaSota. In vitro growth characteristics and a pathogenicity test indicated that all three chimeric viruses retained the highly attenuated phenotype of the parental viruses. Immunization of chickens with chimeric and full-length genome VII vaccines followed by challenge with virulent Ban/010 or Texas GB (genotype II) virus demonstrated protection against clinical disease and death. However, only those chickens immunized with chimeric rLaSota expressing the F or F plus HN proteins of the Indonesian strain were efficiently protected against shedding of Ban/010 virus. Our findings showed that genotype-matched vaccines can provide protection to chickens by efficiently preventing spread of virus, primarily due to the F protein.
format Online
Article
Text
id pubmed-3755997
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37559972013-09-06 Newcastle Disease Virus Fusion Protein Is the Major Contributor to Protective Immunity of Genotype-Matched Vaccine Kim, Shin-Hee Wanasen, Nanchaya Paldurai, Anandan Xiao, Sa Collins, Peter L. Samal, Siba K. PLoS One Research Article Virulent strains of Newcastle disease virus (NDV) can cause devastating disease in chickens worldwide. Although the current vaccines are substantially effective, they do not completely prevent infection, virus shedding and disease. To produce genotype-matched vaccines, a full-genome reverse genetics system has been used to generate a recombinant virus in which the F protein cleavage site has been changed to that of avirulent vaccine virus. In the other strategy, the vaccines have been generated by replacing the F and HN genes of a commercial vaccine strain with those from a genotype-matched virus. However, the protective efficacy of a chimeric virus vaccine has not been directly compared with that of a full-genome virus vaccine developed by reverse genetics. Therefore, in this study, we evaluated the protective efficacy of genotype VII matched chimeric vaccines by generating three recombinant viruses based on avirulent LaSota (genotype II) strain in which the open reading frames (ORFs) encoding the F and HN proteins were replaced, individually or together, with those of the circulating and highly virulent Indonesian NDV strain Ban/010. The cleavage site of the Ban/010 F protein was mutated to the avirulent motif found in strain LaSota. In vitro growth characteristics and a pathogenicity test indicated that all three chimeric viruses retained the highly attenuated phenotype of the parental viruses. Immunization of chickens with chimeric and full-length genome VII vaccines followed by challenge with virulent Ban/010 or Texas GB (genotype II) virus demonstrated protection against clinical disease and death. However, only those chickens immunized with chimeric rLaSota expressing the F or F plus HN proteins of the Indonesian strain were efficiently protected against shedding of Ban/010 virus. Our findings showed that genotype-matched vaccines can provide protection to chickens by efficiently preventing spread of virus, primarily due to the F protein. Public Library of Science 2013-08-28 /pmc/articles/PMC3755997/ /pubmed/24015313 http://dx.doi.org/10.1371/journal.pone.0074022 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
Kim, Shin-Hee
Wanasen, Nanchaya
Paldurai, Anandan
Xiao, Sa
Collins, Peter L.
Samal, Siba K.
Newcastle Disease Virus Fusion Protein Is the Major Contributor to Protective Immunity of Genotype-Matched Vaccine
title Newcastle Disease Virus Fusion Protein Is the Major Contributor to Protective Immunity of Genotype-Matched Vaccine
title_full Newcastle Disease Virus Fusion Protein Is the Major Contributor to Protective Immunity of Genotype-Matched Vaccine
title_fullStr Newcastle Disease Virus Fusion Protein Is the Major Contributor to Protective Immunity of Genotype-Matched Vaccine
title_full_unstemmed Newcastle Disease Virus Fusion Protein Is the Major Contributor to Protective Immunity of Genotype-Matched Vaccine
title_short Newcastle Disease Virus Fusion Protein Is the Major Contributor to Protective Immunity of Genotype-Matched Vaccine
title_sort newcastle disease virus fusion protein is the major contributor to protective immunity of genotype-matched vaccine
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755997/
https://www.ncbi.nlm.nih.gov/pubmed/24015313
http://dx.doi.org/10.1371/journal.pone.0074022
work_keys_str_mv AT kimshinhee newcastlediseasevirusfusionproteinisthemajorcontributortoprotectiveimmunityofgenotypematchedvaccine
AT wanasennanchaya newcastlediseasevirusfusionproteinisthemajorcontributortoprotectiveimmunityofgenotypematchedvaccine
AT palduraianandan newcastlediseasevirusfusionproteinisthemajorcontributortoprotectiveimmunityofgenotypematchedvaccine
AT xiaosa newcastlediseasevirusfusionproteinisthemajorcontributortoprotectiveimmunityofgenotypematchedvaccine
AT collinspeterl newcastlediseasevirusfusionproteinisthemajorcontributortoprotectiveimmunityofgenotypematchedvaccine
AT samalsibak newcastlediseasevirusfusionproteinisthemajorcontributortoprotectiveimmunityofgenotypematchedvaccine